Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation-Reference-Cited by-同舟云学术

Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation

Published:2024-04-16 Issue:9 Volume:16 Page:859-872
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Cheshmazar Narges¹^ORCID,Hamzeh-Mivehroud Maryam¹²^ORCID,Hemmati Salar³^ORCID,Abolhasani Hoda⁴⁵^ORCID,Heidari Fatemeh⁴^ORCID,Charoudeh Hojjatollah Nozad⁶^ORCID,Zessin Matthes⁷,Schutkowski Mike⁷^ORCID,Sippl Wolfgang⁸^ORCID,Dastmalchi Siavoush¹²⁹^ORCID

Affiliation:

1. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran

2. Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 5166414766, Iran

3. Drug applied research Center, Tabriz University of Medical Sciences, Tabriz, 5165665811, Iran

4. Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran

5. Department of Pharmacology, School of Medicine, Qom University of Medical Sciences, Qom, Iran

6. Anatomical Sciences Department, Faculty of Medicine, Tabriz University of Medical, Tabriz, 5166614766, Iran

7. Department of Enzymology, Institute of Biochemistry, Martin-Luther-University Halle-Wittenberg, Halle/Saale, 06120, Germany

8. Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle/Saale, 06120, Germany

9. Faculty of Pharmacy, Near East University, PO Box 99138, Nicosia, North Cyprus, Mersin, 10, Turkey

Funder

Research Office and Biotechnology Research Center of Tabriz University of Medical Sciences

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.4155/fmc-2023-0122

Reference34 articles.

1. Biology of Cancer; From Cellular Cancerogenesis to Supracellular Evolution of Malignant Phenotype

2. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk;Takeshima H;NPJ Precis. Oncol.,2019

3. Awareness and current knowledge of breast cancer

4. Histone Modifications and Cancer

5. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy